Tomohisa Nezu

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study

Naohisa Hosomi, Yoji Nagai, Tatsuo Kohriyama et al. · EBioMedicine · 2015 · 121 citations · Full text

Early Ischemic Change on CT Versus Diffusion-Weighted Imaging for Patients With Stroke Receiving Intravenous Recombinant Tissue-Type Plasminogen Activator Therapy

Tomohisa Nezu, Masatoshi Koga, Jyoji Nakagawara et al. · Stroke · 2011 · 121 citations

Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA

Tomohisa Nezu, Masatoshi Koga, Kazumi Kimura et al. · Neurology · 2010 · 103 citations

Controlling nutritional status score for predicting 3-mo functional outcome in acute ischemic stroke

Hiroyuki Naito, Tomohisa Nezu, Naohisa Hosomi et al. · Nutrition · 2018 · 80 citations · Full text

Nutrition, Cerebrovascular Disease, Neurological Rehabilitation +18